Nomad Foods, the new owners of Birds Eye and Findus’ European assets, has said that it is hungry for more deals.
Nomad, which was set up as a cash vehicle by consumer goods tycoons Martin E Franklin and Noam Gottesman, said that revenues fell by 2.4pc in the year to the end of June.
The group, which bought fish finger maker Iglo Group for €2.6bn (£1.9bn) in April, added Findus Foods’ European business for £500m earlier this month.
The combined group posted a €536m post-tax loss for the year, after various costs and charges relating to the Iglo acquisition.
Stefan Descheemaeker, Nomad’s chief executive, said the results were in line with expectations, given the difficult retail environment across the group’s core geographies.
The food boss said that Nomad had increased promotions on some of its products to appeal to value-seeking customers, while introducing new items, such as wholegrain chicken nuggets, across its markets.
“As we look to the future, we believe Nomad is well positioned to take advantage of numerous growth opportunities across Western Europe and globally, not only within the frozen food category, but also within the broader packaged food space” said Mr Descheemaeker.
“Stéfan and his team have created a strong platform to lead the consolidation in the fragmented global food sector”, Mr Gottesman said.
“The Iglo acquisition is performing as expected and we are excited about other potential acquisition opportunities that meet our criteria of being leaders in niche markets and having a long history of strong free cash flow generation.
“The momentum we have achieved thus far in 2015 have us well positioned to achieve meaningful long-term growth both organically as well as through prudent and complementary M&A opportunities.”
Nomad raised $485m from an initial public offering in April 2014 to fund acquisitions in the food and beverage industry. The group raised a further $330m in July to finance its dealmaking.
Nomad has won support from Bill Ackman, the founder of activist hedge fund Pershing Square, who revealed he had 22pc stake in June.
By Ashley Armstrong
Source: The Telegraph
Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.
US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.
Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.